Estimaciones de analistas de Wall Street para Silence Therapeutics plc (SLN): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 5.00 |
| EV / EBITDA | -9.01 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $770000 | $16000 | 0 | $244000 | $5.5M | $12.4M | $17.7M | $25.4M | $43.3M | $559000 |
| Coste de Ventas | $8.7M | $7.9M | $9.7M | 0 | $3.8M | $7.5M | $11.0M | $10.3M | $11.8M | $215000 |
| Beneficio Bruto | -$7.9M | -$7.9M | -$9.7M | $244000 | $1.7M | $5.0M | $6.7M | $15.1M | $31.4M | $344000 |
| I+D | $8.7M | $7.9M | $9.7M | $13.3M | $20.2M | $30.8M | $35.5M | $44.0M | $67.9M | $67.8M |
| Generales y Administrativos | $4.0M | $6.5M | $10.8M | $9.6M | $14.0M | $20.0M | $20.9M | $20.6M | $26.9M | $22.3M |
| Gastos Operativos | $4.0M | $6.5M | $10.8M | $23.0M | $37.6M | $50.8M | $56.4M | $64.7M | $94.8M | $90.1M |
| Beneficio Operativo | -$11.9M | -$14.4M | -$20.6M | -$22.7M | -$35.8M | -$45.8M | -$49.8M | -$49.6M | -$63.3M | -$89.8M |
| EBITDA | -$11.6M | -$3.3M | -$20.2M | -$22.4M | -$35.5M | -$45.4M | -$39.9M | -$49.8M | -$49.0M | -$88.0M |
| Gastos por Intereses | 0 | $15000 | 0 | $33000 | $16000 | $8000 | $47000 | $34000 | 0 | 0 |
| Beneficio Antes de Impuestos | -$10.4M | -$3.8M | -$20.5M | -$22.9M | -$36.0M | -$45.9M | -$40.5M | -$50.3M | -$44.5M | -$88.6M |
| Impuestos | -$1.9M | -$2.2M | -$2.1M | -$3.3M | -$3.5M | -$6.4M | $560854 | -$7.0M | $845000 | $11000 |
| Beneficio Neto | -$8.4M | -$1.6M | -$18.4M | -$19.6M | -$32.5M | -$39.4M | -$41.0M | -$43.3M | -$45.3M | -$88.6M |
| BPA | $-0.36 | $-0.07 | $-0.78 | $-0.78 | $-1.11 | $-1.35 | $-3.78 | $-3.48 | $-2.37 | $-5.67 |
| BPA Diluido | $-0.36 | $-0.07 | $-0.78 | $-0.78 | $-1.11 | $-1.35 | $-3.78 | $-3.48 | $-2.37 | $-5.67 |
| Acciones en Circulación (Diluidas) | $23.3M | $23.3M | $23.4M | $25.0M | $27.3M | $29.7M | $10.7M | $12.4M | $15.4M | $15.7M |
Precio
| Precio | $12.50 |
| Capitalización | $590M |
| Bolsa | NASDAQ |
| País | GB |
Empresas relacionadas: ACIU · ALDX · AMRN · ANRO · CAPR · CTNM · KYTX
Explorar sector: Healthcare · Biotechnology
Más secciones de SLN: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones